Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Michailidis

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|November 6, 2025
Novel Dimeric Capsid Assembly Modulators as a Unique Class of Highly Potent Anti-HBV AgentsFranck Amblard, Zhe Chen, Kalouna Kra, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2020
Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytesEleftherios Michailidis, Koen Vercauteren, Liliana Mancio-Silva, et al.
Open Forum Infectious Diseases|November 7, 2025
Whole-Genome Sequencing of Hepatitis B Virus Genotypes E and A in Zambia Reveals Limited Viral Diversity in HIV CoinfectionMichael J Vinikoor, Andreas Walker, Bright Nsokolo, et al.
Nucleic Acids Research|September 13, 2011
Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptaseTanyaradzwa P Ndongwe, Adeyemi O Adedeji, Eleftherios Michailidis, et al.
Nature Microbiology|July 25, 2020
LY6E impairs coronavirus fusion and confers immune control of viral diseaseStephanie Pfaender, Katrina B Mar, Eleftherios Michailidis, et al.
Science (New York, N.Y.)|October 14, 2021
Replication and single-cycle delivery of SARS-CoV-2 repliconsInna Ricardo-Lax, Joseph M Luna, Tran Thi Nhu Thao, et al.
Cell Reports|September 14, 2022
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric miceMohammad Kabbani, Eleftherios Michailidis, Sandra Steensels, et al.
Cell Host & Microbe|June 7, 2020
A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape MutationsQiao Wang, Eleftherios Michailidis, Yingpu Yu, et al.
Nature Cancer|August 3, 2023
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinomaAlex Rialdi, Mary Duffy, Alex P Scopton, et al.
Science Advances|November 5, 2020
Liver-expressed <i>Cd302</i> and <i>Cr1l</i> limit hepatitis C virus cross-species transmission to miceRichard J P Brown, Birthe Tegtmeyer, Julie Sheldon, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|November 6, 2025
Novel Dimeric Capsid Assembly Modulators as a Unique Class of Highly Potent Anti-HBV AgentsFranck Amblard, Zhe Chen, Kalouna Kra, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2020
Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytesEleftherios Michailidis, Koen Vercauteren, Liliana Mancio-Silva, et al.
Open Forum Infectious Diseases|November 7, 2025
Whole-Genome Sequencing of Hepatitis B Virus Genotypes E and A in Zambia Reveals Limited Viral Diversity in HIV CoinfectionMichael J Vinikoor, Andreas Walker, Bright Nsokolo, et al.
Nucleic Acids Research|September 13, 2011
Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptaseTanyaradzwa P Ndongwe, Adeyemi O Adedeji, Eleftherios Michailidis, et al.
Nature Microbiology|July 25, 2020
LY6E impairs coronavirus fusion and confers immune control of viral diseaseStephanie Pfaender, Katrina B Mar, Eleftherios Michailidis, et al.
Science (New York, N.Y.)|October 14, 2021
Replication and single-cycle delivery of SARS-CoV-2 repliconsInna Ricardo-Lax, Joseph M Luna, Tran Thi Nhu Thao, et al.
Cell Reports|September 14, 2022
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric miceMohammad Kabbani, Eleftherios Michailidis, Sandra Steensels, et al.
Cell Host & Microbe|June 7, 2020
A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape MutationsQiao Wang, Eleftherios Michailidis, Yingpu Yu, et al.
Nature Cancer|August 3, 2023
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinomaAlex Rialdi, Mary Duffy, Alex P Scopton, et al.
Science Advances|November 5, 2020
Liver-expressed <i>Cd302</i> and <i>Cr1l</i> limit hepatitis C virus cross-species transmission to miceRichard J P Brown, Birthe Tegtmeyer, Julie Sheldon, et al.
Pageof 8